spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:   Valeant Pharmaceuticals 

 HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Feb 2022
Biosion, Inc. Appoints Joel Edwards, MBA, as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jul 2021
Viracta Therapeutics Announces the Appointment of Ayman El-Guindy, Ph.D., as Chief Scientific Officer and Key Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2021
OncoSec Strengthens Management Team With Two New Appointments
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Apr 2019
Neurelis Announces Completion of Senior Management Team Buildout to Support the Anticipated Commercial Launch of VALTOCO(TM)
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 1 Oct 2018
Perrigo Confirms Patent Challenge for Generic Version of Jublia(R) Topical Solution 10%
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 16 Jul 2018
enGene Appoints Veteran Life Sciences Executive Jason D. Hanson as Chief Executive Officer and President
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 26 Jun 2018
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA(TM) (lofexidine)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 8 May 2018
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
Devices Oncology Dermatology Personnel
 HSMN NewsFeed - 8 May 2018
Valeant Will Become Bausch Health Companies Inc.
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 7 May 2018
Salix Receives FDA Approval For PLENVU(R), Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies
Biopharmaceuticals Radiology Gastroenterology FDA
 HSMN NewsFeed - 2 May 2018
Bausch & Lomb ULTRA(R) Contact Lenses Receive FDA Approval for Extended Wear Indication
Devices Ophthalmology FDA
 HSMN NewsFeed - 4 Apr 2018
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2018
Salix Provides Update on FDA Submission for PLENVU(R)
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 29 Dec 2017
Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for AZEDRA(R) (iobenguane I 131) in Pheochromocytoma and Paraganglioma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Dec 2017
Bausch & Lomb Begins Distribution Of VYZULTA(TM) (latanoprostene bunod ophthalmic solution), 0.024% To U.S. Wholesalers
Biopharmaceuticals Ophthalmology Product Launch
 HSMN NewsFeed - 10 Nov 2017
Valeant Pharmaceuticals Completes Sale of Obagi Medical Products Business to Haitong International Zhongua Finance Acquisition Fund I, L.P.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Oct 2017
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
Biopharmaceuticals Generics Dermatology Litigation
 HSMN NewsFeed - 24 Oct 2017
KNOW Bio Strengthens Leadership with the Addition of Four New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2017
Ortho Dermatologics Announces Two-Year Findings From Pivotal Phase 3 Study Of SILIQ(TM) (brodalumab) Injection Data Demonstrating Long-Term Efficacy Profile
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 4 Oct 2017
Solta Medical Receives FDA 510(k) Clearance for Thermage FLX(TM) System, Newest Generation Skin Smoothing Technology
Devices Dermatology FDA
 HSMN NewsFeed - 29 Sep 2017
Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific Equity Partners And The Carlyle Group
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Jul 2017
Valeant Announces U.S. Launch of SILIQ(TM) (brodalumab) Injection
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 17 Jul 2017
Valeant Agrees To Sell Obagi Medical Products Business
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 8 Jun 2017
Valeant Announces Sale of iNova Pharmaceuticals for $930 Million
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 May 2017
Bausch & Lomb Introduces renu(R) Advanced Formula Multi-Purpose Solution
Biopharmaceuticals Ophthalmology Product Launch
 HSMN NewsFeed - 17 May 2017
Statement Regarding Xifaxan Intellectual Property Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 26 Apr 2017
Bausch & Lomb Receives 510(k) Clearance From FDA For Vitesse(TM), The First And Only Hypersonic, Open-Port Vitrectomy System
Devices Ophthalmology FDA
 HSMN NewsFeed - 25 Apr 2017
Magnolia Medical Appoints Robert E. Gerberich As Chief Commercial Officer
Devices Diagnostics Personnel
 HSMN NewsFeed - 21 Apr 2017
Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ(TM) (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 30 Mar 2017
Bausch & Lomb ULTRA(R) for Astigmatism Contact Lenses Introduced
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 24 Mar 2017
Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 15 Mar 2017
Bausch & Lomb Introduces Biotrue(R) ONEday For Astigmatism Contact Lenses
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 21 Feb 2017
Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 16 Feb 2017
Valeant Receives FDA Approval Of SILIQ(TM) (Brodalumab) For Moderate-To-Severe Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 23 Dec 2016
Progenics Pharmaceuticals Announces Independent Committee’s Positive Recommendation for Continuation of Phase 3 Clinical Trial of SPECT/CT Imaging Agent 1404
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Dec 2016
Valeant Appoints William D. Humphries As EVP, Dermatology
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 8 Dec 2016
Pharming Announces Completion of Acquisition of All North American Commercialisation Rights for RUCONEST(R) From Valeant
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 11 Nov 2016
CHMP Adopts Positive Opinion to Include Self-administration for RUCONEST(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution
 HSMN NewsFeed - 31 Oct 2016
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Aug 2016
Elite Announces Development and License Agreement with SunGen Pharma LLC
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 22 Aug 2016
Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 1 Jul 2016
Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Jun 2016
Valeant Pharmaceuticals Announces Launch Of New PreserVision(R) AREDS 2 Formula + Multivitamin
Biopharmaceuticals Ophthalmology Product Launch
 HSMN NewsFeed - 9 Jun 2016
Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 May 2016
Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2016
Elite Pharmaceuticals to Present SequestOx(TM) Data at the American Pain Society 35th Annual Scientific Meeting
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 5 May 2016
Valeant Pharmaceuticals Announces Collaboration Between Bausch & Lomb And IBM
Devices Surgery Ophthalmology
 HSMN NewsFeed - 4 May 2016
Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2016
Joseph C. Papa Assumes Role Of Chairman And Chief Executive Officer Of Valeant Pharmaceuticals
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 12 Apr 2016
Elite Pharmaceuticals Announces Changes to their Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2016
Pharming Announces Adoption by the European Commission of the CHMP Recommendation to Change the Terms of the Marketing Authorisation for Ruconest(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Apr 2016
Eiger BioPharmaceuticals Strengthens Board of Directors with Addition of Industry Veteran Charles J. "Chuck" Bramlage
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2016
Elite Announces U.S. FDA Priority Review Designation for SequestOx(TM) NDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Mar 2016
Valeant Pharmaceuticals Announces The Addition Of Three New Independent Directors To Its Board
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 3 Mar 2016
Valeant Pharmaceuticals Comments On Management Change
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 29 Feb 2016
Allergan Announces Receipt Of FDA Acceptable For Filing Letter For Generic XIFAXAN(R) ANDA
Biopharmaceuticals Generics Gastroenterology FDA
 HSMN NewsFeed - 25 Jan 2016
Valeant Announces FDA Acceptance of BLA Submission for Brodalumab in Moderate-to-Severe Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 13 Jan 2016
Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Dec 2015
Valeant Announces J. Michael Pearson Will Be On Medical Leave of Absence
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 1 Dec 2015
NuVasive Appoints Jason D. Hanson as Executive Vice President, Strategy, Corporate Development and General Counsel
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 7 Oct 2015
Novan Appoints Chief Financial Officer and Chief Commercial Officer to Leadership Team
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 17 Sep 2015
Impax Receives FDA Approval for Generic Version of Mestinon(R) Timespan(R) Tablets, 180 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 Sep 2015
Valeant And AstraZeneca To Partner On Brodalumab
Biopharmaceuticals Dermatology Licensing Distribution
 HSMN NewsFeed - 27 Aug 2015
InSite Vision and QLT Amend Merger Agreement
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2015
Valeant Pharmaceuticals To Acquire Sprout Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Jul 2015
Valeant Pharmaceuticals Agrees To Acquire Amoun Pharmaceutical
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 29 Apr 2015
Valeant Announces CFO Succession Plan And Additional Executive Appointment
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 13 Jan 2015
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Nov 2014
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON(TM) Gel For The Treatment Of Acne Vulgaris
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 9 Oct 2014
Angiotech Appoints John Barr as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2014
EarlySense Welcomes Mr. John Barr as a New Member to the Board of Directors
Devices Monitoring Personnel
 HSMN NewsFeed - 29 Sep 2014
Allergan Board of Directors Issues Statement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Sep 2014
Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant Pharmaceuticals
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 11 Aug 2014
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jul 2014
Bausch + Lomb's VICTUS(R) Femtosecond Laser Platform Receives 510(k) Clearance from FDA for Lens Fragmentation Procedure
Devices Ophthalmology FDA
 HSMN NewsFeed - 30 Jun 2014
Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 28 May 2014
Allergan Confirms Receipt of Revised, Unsolicited Proposal from Valeant
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 May 2014
Allergan Board Unanimously Rejects Unsolicited Proposal from Valeant
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Feb 2014
Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 31 Jan 2014
Valeant Pharmaceuticals Announces Approval of Retin-A Micro(R) Microsphere 0.08%
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 24 Jan 2014
Valeant Pharmaceuticals International, Inc. Completes Acquisition of Solta Medical, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 15 Jan 2014
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 14 Jan 2014
Ipsen to set up its own US oncology team for Somatuline(R) Depot(R) (lanreotide) Injection in neuroendocrine tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Dec 2013
InSite Vision Announces Positive Confirmatory Phase 3 Results for BromSite(TM) for the Reduction of Inflammation and Pain after Cataract Surgery
Biopharmaceuticals Drug Delivery Ophthalmology Surgery
 HSMN NewsFeed - 16 Dec 2013
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 2 Dec 2013
Evoke Pharma Strengthens Executive Team With Appointments of Chief Medical Officer and Senior Director of Clinical Operations
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 2 Dec 2013
Glenmark Announces Appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2013
Valeant Pharmaceuticals Announces U.S. Approval Of Luzu(R) Cream, 1%
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 28 Oct 2013
Valeant Pharmaceuticals Announces Settlement Agreement With Anacor
Biopharmaceuticals Litigation
 HSMN NewsFeed - 18 Oct 2013
Valeant Pharmaceuticals Announces Award In Anacor Dispute
Biopharmaceuticals Litigation
 HSMN NewsFeed - 11 Oct 2013
Timothy C. Tyson Joins the Board of Caldera Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Oct 2013
Valeant Pharmaceuticals Announces Approval Of Jublia(R) For The Treatment Of Onychomycosis In Canada
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 6 Aug 2013
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch & Lomb
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 2 Jul 2013
Mentor Announces Collaboration Agreement With Valeant Pharmaceuticals
Devices Distribution
 HSMN NewsFeed - 2 May 2013
Hyperion Therapeutics Exercises Option to Acquire Rights to BUPHENYL(R) and AMMONUL(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 1 May 2013
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 5 Apr 2013
Actavis and Valeant Announce Actavis as Exclusive Authorized Generic Marketer of Zovirax(R) Ointment; Co-Promotion Agreements on Zovirax(R) Cream and Cordran(R) Tape
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 20 Mar 2013
Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 21 Feb 2013
Valeant Pharmaceuticals Acquires U.S. Rights to Targretin(R) from Eisai Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 3 Jan 2013
Valeant Pharmaceuticals Announces New Management Appointment
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 18 Dec 2012
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Dec 2012
QLT Announces Reduction in Force
Biopharmaceuticals
 HSMN NewsFeed - 28 Nov 2012
Valeant Pharmaceuticals Announces New Management Appointments
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 24 Sep 2012
QLT Announces Sale of Visudyne(R) to Valeant Pharmaceuticals
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 18 Sep 2012
Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 3 May 2012
Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 2 May 2012
Gentium Appoints PharmaSwiss, S.A. as Exclusive Distributor of Defibrotide in Central and Eastern European Countries
Biopharmaceuticals Distribution
 HSMN NewsFeed - 12 Apr 2012
Valeant Pharmaceuticals to Acquire Pedinol
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Feb 2012
Valeant Pharmaceuticals to Acquire Eyetech
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 30 Jan 2012
Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc.
Biopharmaceuticals
 HSMN NewsFeed - 19 Dec 2011
Valeant Pharmaceuticals Completes Acquisition of Dermik
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 16 Dec 2011
Valeant Announces Successful Results From Phase III Onychomycosis Trials
Biopharmaceuticals
 HSMN NewsFeed - 8 Nov 2011
Nautilus Neurosciences Appoints Peter Lankau as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Aug 2011
Valeant Pharmaceuticals Appoints Ronald Farmer to Fill Board Vacancy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2011
Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
Biopharmaceuticals
 HSMN NewsFeed - 11 Jul 2011
Valeant Pharmaceuticals Agrees to Acquire Dermik
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 13 Jun 2011
Valeant and GlaxoSmithKline Announce U.S. FDA Approval of Potiga (ezogabine)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 May 2011
Valeant Pharmaceuticals Agrees to Acquire Sanitas Group for Approximately EUR314 Million in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Apr 2011
Meda to License Elidel to Valeant Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Apr 2011
Promius Pharma and Valeant Form Collaboration to Market Cloderm(R) Cream in the United States
Biopharmaceuticals Dermatology Distribution
 HSMN NewsFeed - 28 Mar 2011
Janet Hammond Joins Roche as Vice President, Translational Medicine - Virology
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2011
Pearl Therapeutics Appoints Charles (Chuck) Bramlage President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Feb 2011
Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 1 Feb 2011
Valeant Pharmaceuticals to Acquire PharmaSwiss S.A.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Jan 2011
Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 6 Dec 2010
Elan Names Robert A. Ingram Chairman-Designate
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2010
Valeant Pharmaceuticals and Gradient Analytics Settle Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 28 Oct 2010
ACADIA Pharmaceuticals Enters Agreement with Biovail to Conclude Collaboration and Regain North American Rights to Pimavanserin
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2010
Valeant and Biovail Complete Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Aug 2010
Meda: Ezogabine Receives Positive Vote From FDA Advisory Committee
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Jun 2010
Valeant Pharmaceuticals Resumes Shipment of Oxsoralen-Ultra(R)
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 21 Jun 2010
Valeant and Biovail Agree to Merge
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 May 2010
Valeant Pharmaceuticals Announces Regulatory Approval of Onsolis(TM) in Canada
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 21 Apr 2010
Valeant to Acquire Pharmaceutical Company in Brazil
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Apr 2010
Galen Partners Invests in Nautilus Neurosciences, Inc.
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 11 Jan 2010
Teleflex Incorporated Names Richard (Randy) Meier Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 30 Dec 2009
FDA Accepts NDA Filing for Retigabine
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Nov 2009
NeurogesX Expands Commercial Operations Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2009
Mylan Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment
Biopharmaceuticals Generics Dermatology
 HSMN NewsFeed - 29 Jul 2009
Valeant to Acquire Tecnofarma, A Mexican Generic Company
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 25 Jun 2009
Richard A. Meier Appointed to STAAR Surgical Board of Directors
Devices Ophthalmology Personnel
 HSMN NewsFeed - 6 Mar 2009
Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Jan 2009
Valeant Pharmaceuticals Completes Acquisition of Dow Pharmaceutical Sciences, Inc.
Biopharmaceuticals Acquisitions Dermatology
 HSMN NewsFeed - 10 Dec 2008
Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 14 Nov 2008
VALEANT PHARMACEUTICALS ACQUIRES DERMATECH
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 12 Sep 2008
Meda: Acquisition of European Businesses from Valeant Completed
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 7 Aug 2008
Meda Enters into Joint Venture with Valeant
Biopharmaceuticals
 HSMN NewsFeed - 9 Jun 2008
Senetek PLC Announces Key Personnel Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2008
Charles J. Bramlage Named President of Covidien Pharmaceutical Products Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Valeant Pharmaceuticals Announces FDA Has Initiated Reconsideration of Generic Efudex(R) Approval
Biopharmaceuticals Generics Dermatology FDA
 HSMN NewsFeed - 17 Apr 2008
Zogenix Completes Management Team with Cynthia Robinson, Ph.D., CDO, & Mark Thompson, VP, Sales & Managed Markets
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 6 Feb 2008
Xanodyne Announces Two Senior Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2008
Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 20 Dec 2007
Valeant Pharmaceuticals Sells Hep-C Drug Infergen(R) to Three Rivers Pharmaceuticals(R), LLC for $91 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Nov 2007
Cytheris Appoints Richard Keatinge as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2007
Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2007
Barr and Par Settle Diazepam Rectal Gel Patent Challenge with Valeant
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 1 Oct 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
Biopharmaceuticals
 HSMN NewsFeed - 18 Sep 2007
Valeant Pharmaceuticals Announces the Launch of the zelaCARD for Parkinson's Disease Patients Taking Zelapar(R)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Jul 2007
Artes Medical Names Greg J. Kricorian, M.D. as Its Chief Medical Officer
Devices Dermatology Personnel
 HSMN NewsFeed - 2 Jul 2007
Valeant Pharmaceuticals Settles Suit with Kali Laboratories on Diastat Generic Challenge
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Apr 2007
Valeant Pharmaceuticals Re-Signs Courteney Cox as Kinerase(R) Spokesperson
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 11 Apr 2007
Senetek Initiates Clinical Trials of Pyratine 6 for Acne Rosacea
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 10 Apr 2007
Sharps Compliance Corp. Announces Appointment of Senior Vice President of Sales and Marketing
Devices Personnel
 HSMN NewsFeed - 29 Mar 2007
FDA Announces Voluntary Withdrawal of Pergolide Products
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Feb 2007
Valeant Pharmaceuticals Files Investigational New Drug Application for Cesamet(R) in Cancer Chemotherapy-Induced Neuropathic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Feb 2007
Valeant Pharmaceuticals Acquires Rights to Nabilone in United Kingdom and Europe
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2007
Ardea Biosciences Announces New Corporate Headquarters, New Ticker Symbol, and Appointment of Key R&D Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Feb 2007
JSJ Pharmaceuticals Assumes Sales & Marketing Responsibility of Oxsoralen-Ultra(R) from Valeant Pharmaceuticals International
Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2007
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Jan 2007
Valeant Pharmaceuticals Developing Intranasal Diazepam for the At-Home Treatment of Emergency Seizures
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 17 Jan 2007
John Z. Sullivan-Bolyai, M.D., MPH, Joins Anadys Pharmaceuticals as Vice President, Clinical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jan 2007
Jazz Pharmaceuticals Signs Licensing Agreement With Valeant Pharmaceuticals for Canadian Marketing Rights to Xyrem(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 Dec 2006
Company Announces Acquisition of Research and Development Programs, Hiring of Senior Management Team and Name Change
Biopharmaceuticals Acquisitions Personnel
 HSMN NewsFeed - 21 Dec 2006
Valeant Pharmaceuticals to Relocate Worldwide Corporate Headquarters
Biopharmaceuticals
 HSMN NewsFeed - 13 Dec 2006
Valeant Pharmaceuticals and Metabasis Therapeutics License Rights to Hepatitis B Compound Pradefovir to Schering-Plough Corporation
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Dec 2006
Schering-Plough Licenses Worldwide Rights to Pradefovir, Oral Hepatitis B Treatment In Development With Valeant Pharmaceuticals and Metabasis Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Dec 2006
Valeant Pharmaceuticals Initiates Infergen(R) Phase 4 Study
Biopharmaceuticals
 HSMN NewsFeed - 6 Dec 2006
Epiphany Biosciences Appoints Brian Murphy as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Nov 2006
Par Announces Termination of Cesamet(TM) Promotion Agreement
Biopharmaceuticals
 HSMN NewsFeed - 30 Oct 2006
Valeant Pharmaceuticals Presents End-of-Treatment Results of DIRECT Trial for Infergen at the American Association for the Study of Liver Diseases 2006 Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 10 Oct 2006
Valeant Pharmaceuticals Ltd. to Promote and Distribute Intendis Dermatological Products in the United Kingdom
Biopharmaceuticals Dermatology Distribution
 HSMN NewsFeed - 12 Sep 2006
Valeant Pharmaceuticals Reports VISER2 Results for Viramidine(R)
Biopharmaceuticals
 HSMN NewsFeed - 18 Jul 2006
Valeant Pharmaceuticals Announces Availability of Zelapar(R) for Parkinson's Disease Patients
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 16 May 2006
Valeant Pharmaceuticals Receives FDA Marketing Approval for Cannabinoid Cesamet(TM) (CII)
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 52

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 52 additional stories matching:
Valeant Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.